Telisotuzumab vedotin

(Synonyms: ABBV-399)
2 Cited Publications
Customer Review

Based on 2 publication(s) in Google Scholar

Telisotuzumab vedotin (ABBV-399) (Teliso-V) is an anti-c-Met antibody-drug conjugate. Telisotuzumab vedotin consists of an anti-c-Met monoclonal antibody Telisotuzumab (ABT-700) (HY-P99391) and Monomethyl Auristatin E (HY-15162). Telisotuzumab vedotin exerts antitumor activity with acceptable toxicity in vivo. Telisotuzumab vedotin can be used for non-small cell lung cancer (NSCLC) research.

For research use only. We do not sell to patients.

  • Purity: 99.26%
  • CAS No.: 1714088-51-3
  • Molecular Weight:145000 (average)
  • Storage:

    -80°C, protect from light

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Telisotuzumab vedotin

More
Customer Validation & Images
In Vivo Efficacy StudyIn Vivo Imaging
  • In Vivo Efficacy Study
  • In Vivo Imaging
  • In Vivo Efficacy Study
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00